Document:

Exhibit 10.3

                                LETTER OF INTENT

         The purpose of this Letter of Intent,  dated  effective  as of December
27,  1999,  is to set forth the main  terms  upon  which  TSET,  Inc.,  a Nevada
corporation  ("TSET"),  will acquire 100% of the issued and outstanding  capital
stock of Electron Wind  Technologies,  Inc., a corporation to be formed ("EWT").
The parties in interest  to the  transactions  outlined in this Letter of Intent
are TSET; EWT (to be formed); High Voltage Integrated, LLC, a Washington limited
liability  company ("HVI");  Ingrid Fuhriman,  an individual  owning 20% of HVI;
Robert L. Fuhriman II, an individual owning 20% of HVI; Dr. Igor Krichtafovitch,
an individual  owning 50% of HVI; and Alan Thomson,  an individual owning 10% of
HVI (Ingrid Fuhriman,  Robert L. Fuhriman II, Dr. Igor Krichtafovitch,  and Alan
Thomson are hereinafter collectively referred to as the "Principals").

         TSET, EWT, HVI, and each of the Principals  intend to enter into formal
definitive legal agreements (collectively, the "Definitive Agreements") relating
to such acquisition as soon as practicable after the date hereof, based upon the
terms  described  herein,  which  Definitive  Agreements  shall  set  forth  the
definitive rights,  obligations,  undertakings,  and liabilities of the parties.
The parties'  stated interest in proceeding  expeditiously  to complete and sign
this  Letter  of  Intent  and  the  Definitive  Agreements  is to  their  mutual
satisfaction  and they look  forward to working  together  to  accomplish  these
goals.

         Based  upon  recent  meetings  and  discussions,  the main terms of the
proposed  transactions  among TSET,  HVI, and the Principals  (individually  and
collectively) may be summarized as follows:

         A. INCORPORATION OF ELECTRON WIND TECHNOLOGIES, INC. The parties intend
that TSET effect the  incorporation of EWT under the laws of either the State of
Delaware  or the  State  of  Nevada  (to be  determined  by TSET) as part of the
above-mentioned  formal  legal  documentation.   The  parties  intend  that  EWT
constitute the operating  entity for purposes of their future  relationship,  as
described  herein;  provided,  however,  that the  Principals  intend  to retain
discretion  whether  to  continue  the  corporate  existence  of HVI  and  their
respective ownership interests therein.

         B. ISSUANCE OF SHARES.  The parties  intend that TSET own 100% of EWT's
issued and  outstanding  shares,  in exchange for  2,000,000  TSET  "investment"
shares (the "TSET  Shares").  The parties  intend that the TSET Shares be issued
and allocated as will be designated  in writing by the  Principals.  The parties
intend that any finder's or broker's fees or other  compensation  payable by HVI
or the Principals to any other person shall be paid out of the TSET Shares or in
such other  manner as HVI,  the  Principals,  and any such  finder or broker may
agree, any such compensation being for the account of HVI and the Principals.

         C. TRANSFER OF RIGHTS. The parties intend that, in consideration of the
issuance of the TSET Shares  described in item B above,  HVI and the Principals,
individually and collectively,  sell,  assign,  and transfer to EWT all existing
right,  title,  and  interest  in and to any and all  patents,  trademarks,  and
servicemarks,  and  including  all  improvements  and  derivatives  thereof  and
applications  relating  thereto,  and all other related  intellectual  property,
know-how, licenses, and contract rights of any kind, character, and description,

<PAGE>

all pertaining to that certain  technology  commonly  referred to by HVI and the
Principals as the "electron wind generator" (collectively, the "Technology").

         D.  MANAGEMENT.  The  parties  intend  that  those  of  the  Principals
currently having executive management responsibility for HVI also have strategic
decision-making  and day-to-day  management  responsibility over EWT's business,
business  development,   operations,  marketing,  intellectual  property  rights
protection, and finances, with the Principals to at all times seek in good faith
to advance the best business  interests of EWT and the further  development  and
widespread  exploitation  and deployment of the  Technology.  The parties intend
that TSET be  entitled  to  designate  at least one  director  to EWT's board of
directors.  HVI and the  Principals  have  informed TSET that no oral or written
compensation  arrangements  or agreements  have been entered  into,  and that no
shares, units, or warrants or options to acquire the same have been orally or in
writing granted to or are owned by, HVI's four advisory board members.

         E. BUSINESS PURPOSE.  The parties intend that EWT shall concentrate its
efforts  on the  further  development  and  improvement  of the  Technology  for
licensing,  deployment, and exploitation in a full range of automotive,  medical
equipment,  hotel, home, and  hospital/clinic  applications  (collectively,  the
"Core Applications"). In the event applications of the Technology other than the
Core  Applications  (in any case, an "Alternative  Application")  appear viable,
TSET and EWT will give  consideration  to providing a "grant-back" to HVI or the
Principals (as the case may be) of patent or other intellectual  property rights
on a  case-by-case  basis  for the  specific  fields  of use  pertaining  to the
Alternative  Application in question,  so long as (1) TSET and EWT do not desire
to pursue such  Alternative  Application and (2) the pursuit of such Alternative
Application  does not materially  interfere  with, or divert  significant  time,
attention, and resources away from the development, improvement, deployment, and
licensing of the Core Applications.

         F.  SECURING  OF  SERVICES.  The  parties  intend  that EWT enter  into
long-term employment agreements with, and obtain "key-person" insurance upon, at
least Dr. Igor Krichtafovitch and Robert L. Fuhriman II. All expenses associated
with the matters described in this item F shall be borne by EWT.

         G.  INITIAL  FUNDING.  The parties  intend that TSET assist and support
EWT's capital-raising efforts, to provide EWT with projected initial operational
funding needs of up to $500,000 over the 6-month next following execution of the
Definitive  Agreements  (the  "Initial  Funding"),  all to be  described in more
detail by the  Principals  in a written "use of proceeds" to be provided to TSET
no later than 21 days following execution of this Letter of Intent, and pursuant
to  operating  budgets to be approved by EWT's board of  directors.  The parties
intend that EWT's management be responsible for the establishment of appropriate
guidelines and accounting procedures and the prudent and appropriate  budgeting,
conservation,  and  expenditure of EWT's  financial  resources,  all with a view
toward  the  further  development,  improvement,  exploitation,  marketing,  and
licensing of the  Technology in the Core  Applications  and the  perfection  and
policing  in the U.S.  and  appropriate  global  markets  of  patent  and  other
intellectual  property  rights and  confidentiality  arrangements.  The  parties
intend that, as necessary,  TSET will use its own shares arrange for the Initial
Funding;  provided,  however,  that TSET does not assume or obligate itself with

Page 2

<PAGE>

respect to the indebtedness,  operating expenses, or other financial liabilities
of HVI or any of the Principals.

         H. FUTURE EVENTS.  The parties intend that TSET and EWT will consider a
spin-off of EWT into its own  public-owned  entity  (through  reverse  merger or
other  appropriate  mechanism) at a mutually agreed time in the future (to occur
no  earlier  than  12-18  months  after  the  occurrence  of  a  mutually-agreed
"kick-off"  date). The parties intend that TSET and its designees will retain an
appropriate  ownership interest in EWT's publicly-owned  successor,  as the case
may be.

         I. PRESS  RELEASE.  The parties intend to collaborate on the content of
an appropriate press announcement  regarding the transactions outlined herein to
be released by TSET upon signing this Letter of Intent.

         J.  UNDERTAKING  OF GOOD  FAITH.  Realizing  that  they are  unable  to
anticipate and provide for every  contingency  which may arise during the course
of their  relationship,  the parties intend that  principles of commercial  good
faith  will  govern  and that they will at all times  seek to  advance  the best
interests of EWT and maximize the economic  value of the  Technology in the Core
Applications  (and  such  Alternative  Applications  as EWT and  TSET  agree  to
pursue).

         K.  PURPOSE OF THE LETTER OF INTENT.  This Letter of Intent is intended
by the parties as a statement of their  interests  and mutual intent to complete
the  Definitive  Agreements  in a form  reflective of the business and financial
items for the  purposes  indicated  herein  and shall not be deemed of itself to
grant any binding,  enforceable, or exclusive rights in or to the TSET Shares or
the Technology, or constitute any right, obligation, offer, or commitment of any
of the parties to enter into the Definitive Agreements.  The parties intend that
all rights,  obligations,  or  commitments  to proceed with any  transaction  or
relationship shall be contained only in the Definitive  Agreements signed by all
the  parties.  The parties do not intend that any of them be bound to each other
by this Letter of Intent for damages,  expenses,  failure to finally  agree upon
the terms and conditions of the Transaction Documents,  or in any other way. The
parties  intend  that  the  Definitive  Agreements  regarding  the  transactions
outlined  in this Letter of Intent be prepared  and signed by the  parties,  all
acting in good faith, as soon as practicable after the date hereof.  The parties
intend that the  Definitive  Agreements  contain  appropriate  customary  terms,
conditions,  representations,  and warranties, including appropriate disclosures
by HVI and the  Principals  relating to such  matters as  intellectual  property
ownership,  material  contracts,  taxes,  litigation,  absence  of  breaches  or
defaults  in  legal  obligations,  authority  and  capacity  to  enter  into the
transactions  outlined herein,  outstanding  proxies,  ownership of warrants and
options,  and the like.  The  parties  intend  that each of them will bear their
respective costs and expenses associated herewith and the transactions  outlined
herein.

         L.  CONFIDENTIALITY.  The parties  acknowledge that TSET has previously
entered into the  standard  form  confidentiality  agreement  used by HVI.  TSET
further intends that it will be bound by the provisions of such  confidentiality
agreement  regardless  of  whether  this  Letter  of  Intent  or the  Definitive
Agreements are entered into by the parties, as herein proposed.

         M.  PRIORITY  OF THE LETTER OF INTENT.  Other than as  provided  in the
confidentiality  agreement  mentioned  in item L above,  this  Letter  of Intent

Page 3

<PAGE>

supersedes all prior communications,  understandings,  statements of intent, and
agreements between the parties with respect to the subject matter hereof.

                                      *****

         The parties' execution in the space provided below shall evidence their
respective acceptance of the terms of this Letter of Intent and that they intend
to proceed as outlined herein.

TSET, Inc.

By:      /s/ Jeffrey D. Wilson
         ------------------------------------------------
         Jeffrey D. Wilson
         Chairman and Chief Executive Officer

HIGH VOLTAGEINTEGRATED, LLC

By:      /s/ Ingrid T. Fuhriman
         ------------------------------------------------

         Name: Ingrid T. Fuhriman
               ------------------------------------------
         Authorized Signatory

         /s/ Ingrid T. Fuhriman                   12-27-99
         -------------------------------------------------
         Ingrid Fuhriman, individually, and as a member of
                High Voltage Integrated, LLC

         /s/ Robert L. Fuhriman II                12-27-99
         -------------------------------------------------
         Robert L. Fuhriman II, individually, and as a
                member of High Voltage Integrated, LLC

         /s/ Igor Krichtafovitch                  12-27-99
         -------------------------------------------------
         Dr. Igor Krichtafovitch, individually, and as a
                member of High Voltage Integrated, LLC

         /s/ Alan Thomson                         12-27-99
         -------------------------------------------------
         Alan Thomson, individually, and as a member
                of High Voltage Integrated, LLC

     I. Definitive  agreements regarding the proposed acquisition to be prepared
and signed by the parties as soon as  practicable  after the date  hereof.  Such
agreements to contain appropriate customary terms, conditions,  representations,
and  warranties.  TSET  and  Atomic  Soccer  will  each  bear  their  respective
transaction costs.

     IN WITNESS  WHEREOF,  the parties  have  executed and  delivered  this Deal
Outline effective as of the date first written above.

TSET, Inc.

By      /s/ Jeffrey D. Wilson
        Jeffrey D. Wilson
        Chairman and Chief Executive Officer

ATOMIC SOCCER USA, LTD.

By:     /s/ Todd Ragsdale
        Todd Ragsdale
        President

                                       2

<PAGE>EXHIBIT 10.4

                                    AGREEMENT

                                     BETWEEN

                                 DIAURAL L.L.C.

                                       AND

                                 EDGE AUDIO, LLC

--------------------------------------------------------------------------------

<PAGE>

                                    AGREEMENT

This  Agreement  is  made  and  entered  into  this  5TH day of  FEBRUARY,  2000
(herinafter "EFFECTIVE DATE") by and between DiAural L.L.C., a company organized
and existing  under the laws of the State of Utah,  and having an office at 2752
South 1900 West, Ogden, Utah 84401, U.S.A.  (hereinafter  "LICENSOR"),  and EDGE
AUDIO, LLC, a LIMITED LIABILITY Company organized and existing under the laws of
the State of  Oregon,  and  having an office at 16018 SW  Parker,  Suite A, Lake
Oswego,  OR,  97035  (hereinafter  "LICENSEE"),  all of which  are  collectively
referred to as the "Parties" and, individually, a "Party".

                                 R E C I T A L S

         WHEREAS,  the LICENSOR has acquired certain rights,  title and interest
in and to certain  inventions,  technology,  know-how  and  patent  applications
relating to loudspeaker interface (crossover) technology; and

         WHEREAS,  the LICENSOR is in the process of acquiring  patent rights to
the aforesaid loudspeaker interface (crossover) technology and represents itself
to be the owner of all  right,  title  and  interest  in and to the  loudspeaker
interface  (crossover)  technology  and  to  all  pending  patent  applications,
inventions, technology and know-how requisite for the manufacture, use, sale and
assembly thereof; and

         WHEREAS,  LICENSEE desires to manufacture,  use, market, offer for sale
and otherwise  commercialize  audio products that  incorporate  the  loudspeaker
interface (crossover) technology and associated technology; and

         WHEREAS,  LICENSEE  is also  desirous of using in  connection  with his
manufacturing,  use, marketing, offering for sale and other commercialization of
the  loudspeaker  interface  (crossover)  technology and  associated  technology

                                       1
<PAGE>

certain  trademarks owned by LICENSOR and other trademarks  developed  hereafter
which relate to the loudspeaker interface (crossover) technology; and

         WHEREAS, LICENSEE is desirous of acquiring from LICENSOR a nonexclusive
license  to  manufacture,  market,  sell  and  offer  for  sale  audio  products
incorporating  the  loudspeaker  interface  (crossover)  technology,  associated
technology and know-how,  as needed to  manufacture,  market and sell such audio
products;

         WHEREAS, LICENSEE is desirous of acquiring from LICENSOR a nonexclusive
license to use in connection with his manufacturing,  use,  marketing,  offering
for sale and other  commercialization of the loudspeaker  interface  (crossover)
technology and associated  technology  certain  trademarks owned by LICENSOR and
other trademarks  developed hereafter which relate to the loudspeaker  interface
(crossover) technology; and

         NOW,  THEREFORE,  in consideration of the mutual covenants and promises
contained  herein,  and for good and  valuable  consideration,  the  receipt and
sufficiency of which are hereby acknowledged, LICENSEE and LICENSOR intending to
be legally bound, agree as follows:

                               TERMS OF AGREEMENT

SECTION 1 - DEFINITIONS

         1.1 The term "CROSSOVER TECHNOLOGY" shall mean the technology disclosed
in United States Patent  applications  Serial No.  09/121,753  filed on July 23,
1998,  Serial No.  09/256,040  filed on February  23, 1999,  and foreign  patent
applications   processed   under  the  Patent   Cooperation   Treaty   including
PCT/US98/20826  filed on October 2, 1998 and a PCT filing  corresponding to U.S.
Serial No. 09/256,040 filed on May 6, 1999, which are represented by LICENSOR to
be owned and controlled by LICENSOR.

                                       2
<PAGE>

         1.2  The  term  "LETTERS   PATENT"  shall  mean  United  States  Patent
applications  Serial  No.  09/121,753  filed on July 23,  1998,  and  Serial No.
09/256,040 filed on February 23, 1999, and foreign patent applications processed
under the Patent Cooperation Treaty including PCT/US98/20826 filed on October 2,
1998 and a PCT filing  corresponding to U.S. Serial No.  09/256,040 filed on May
6,  1999,  which  are  represented  to be  owned  by  LICENSOR,  as  well as any
corresponding  United States or foreign Patent or Patents which issue therefrom,
along with any corresponding  United States or foreign  applications or patents,
including  counterparts,   continuation-in-parts,   reissues,   re-examinations,
substitutes thereof and any other patents or patent applications relating to the
CROSSOVER TECHNOLOGY or subsequent improvements thereto.

         1.3 The term  "TECHNICAL  INFORMATION"  as used in this Agreement shall
mean  any  technical  or  business  information,  any  invention,  equipment  or
apparatus,  methods or processes,  technology,  know-how, trade secret, drawing,
data,  evaluation,  specifications,  quantity and  inspection  standards,  sales
literature,  report,  business plan,  memorandum,  market study, customer lists,
training materials,  computer programs or software, or any other documents which
are in whole or in part, whether  confidential or proprietary,  which relates to
the CROSSOVER TECHNOLOGY.

         1.4  The  term  "LICENSED  PRODUCTS"  means  all  products,  equipment,
components,   and  devices  relating  to  CROSSOVER   TECHNOLOGY  and  TECHNICAL
INFORMATION  which are within the scope of at least one pending or issued  claim
of any of the LETTERS  PATENTS,  including  any spare part or  replacement  part
thereof  or any other  component  or  subsystem  which is not  itself a LICENSED
PRODUCT,  the sale of which part,  component,  or subsystem  would,  but for the

                                       3
<PAGE>

license extended herein, be a contributory or other indirect infringement of the
LETTERS PATENT or trade secrets.

         1.5 The term "FINISHED PRODUCT" means a commercially marketable product
that incorporates  LICENSED PRODUCTS into a form factor known by LICENSEE as the
final  integration  of LICENSED  PRODUCTS and  includes  the final  enclosure or
cabinet in the case of audio speakers.

         1.6 The term "NET SALES PRICE" means the cumulative  amounts (including
the receipt of non-cash  items valued at fair market value)  derived by LICENSEE
from  the sale of a  FINISHED  PRODUCT  in an  arms-length  transaction  with an
independent third party, whether for cash, credit or otherwise.

         1.7 The term "TERM OF THE  AGREEMENT"  means the  duration  between the
Effective Date of this Agreement and,  unless  terminated  earlier in accordance
with other provisions of this Agreement,  shall expire upon the date of the last
to expire  LETTERS  PATENT  including  through the  pendency of any filed patent
applications as defined under LETTERS PATENT above.

         1.8 The term  "TERRITORY"  means  any  countries  of the world in which
patents  have been  applied for or issued from  including  the United  States of
America.

SECTION 2 - GRANT OF TECHNOLOGY LICENSE

         2.1 Subject to other terms and conditions set forth in this  Agreement,
the LICENSOR  hereby grants to LICENSEE a personal,  nontransferable  (except if
and as  expressly  provided  below),  nonexclusive  right and license  under the
LETTERS PATENT,  whether pending patent applications for CROSSOVER TECHNOLOGY or
any Letter Patent that may issue therefrom, to manufacture, use, sell, offer for

                                       4
<PAGE>

sale and commercialize  the LICENSED  PRODUCTS  throughout the TERRITORY for the
TERM OF THE AGREEMENT.

         2.2 The right and license granted to LICENSEE under this Agreement does
not  include the right,  directly  or  indirectly  by  implication,  estoppel or
otherwise,  to  sub-license  another.  The sale,  lease or other  disposition by
LICENSEE of a LICENSED  PRODUCT  will not convey,  by  implication,  estoppel or
otherwise,  to the  party to which  the  LICENSED  PRODUCT  is sold,  leased  or
otherwise  transferred,  any  license  or  right  under  the  LICENSED  PRODUCTS
including LETTERS PATENTS and TECHNICAL INFORMATION.

         2.3 LICENSEE agrees that any written  contract entered into by LICENSEE
for the sale,  lease or other  disposition of LICENSED  PRODUCTS shall include a
statement in a form  previously  approved in writing by LICENSOR,  such approval
not to be unreasonably  withheld,  advising the purchaser of (i) the proprietary
nature of the CROSSOVER  TECHNOLOGY  including  identification of LETTERS PATENT
and any patent pending designation,  (ii) and an express  acknowledgment that no
right or license, by implication, estoppel or otherwise, in the LICENSED PRODUCT
is granted to the purchaser.

SECTION 3 - RIGHT AND OBLIGATION TO USE TRADEMARKS

         3.1 The LICENSOR  hereby  grants to LICENSEE a  nonexclusive  right and
obligation  to use the  trademarks  "DIAURAL"  including  related icons or other
trademarks  and icons  (hereinafter  "TRADEMARKS")  specified  by  LICENSOR  for
designating  use of the CROSSOVER  TECHNOLOGY by LICENSEE in LICENSED  PRODUCTS.
The form and substance of the use of  TRADEMARKS  to be  previously  approved in
writing by LICENSOR, such approval not to be unreasonably withheld.

                                       5
<PAGE>

SECTION 4 - REPRESENTATIONS, COVENANTS BY THE PARTIES AND TECHNICAL SUPPORT

         4.1 The LICENSOR and LICENSEE  each  represent and warrant to the other
that they  possess  all the  requisite  power and  authority  to enter into this
Agreement and to perform each and every term, provision,  and obligation of this
Agreement,  and that neither the execution or delivery of this Agreement nor the
performance  of the terms of this  Agreement will conflict with or result in the
breach of any terms,  provisions,  or  obligations  of, or  constitute a default
under any other agreement or instrument under which such Party is obligated.

         4.2 The LICENSOR  hereby  warrants  that it is the owner of the LETTERS
PATENT  and  said  TRADEMARKS  and that it  possesses  the  right  to grant  the
nonexclusive license, as provided herein, to the LICENSED PRODUCTS.

         4.3 There are no other  warranties  of any kind,  express  or  implied,
including,  without  limitation,  implied warranties of fitness for a particular
purpose,  merchantability or title, except for the warranties  expressly set out
in this Agreement. For example, LICENSOR does not warrant or represent: (i) that
any LETTERS PATENT is valid or enforceable;  (ii) that any LICENSED PRODUCT,  or
that the  incorporation  of an  invention  covered  by a LETTERS  PATENT  into a
LICENSED  PRODUCT,  or that the use of any  invention  or  process  covered by a
LETTERS  PATENT,  will not infringe any patent or other  property or proprietary
right of any third party;  or (iii) that LICENSOR will continue to prosecute any
application  constituting  LETTERS PATENT, or maintain any patent constituting a
LETTERS PATENT, or enforce any LETTERS PATENT against any third party.

         4.4 LICENSEE  represents  that it is  technically  proficient,  able to
evaluate  the  purchase   value  of  the  CROSSOVER   TECHNOLOGY  and  TECHNICAL
INFORMATION, and that LICENSEE is able to competently apply the use of CROSSOVER
TECHNOLOGY in the development of LICENSED PRODUCTS.

                                       6
<PAGE>

SECTION 5 - LICENSE FEE AND ROYALTIES

         5.1 LICENSEE  agrees to pay LICENSOR  during the term of this Agreement
fees and royalties as set forth below.

         5.2      LICENSEE agrees to pay LICENSOR:

                  5.2.1 A yearly license fee (hereinafter  "YEARLY LICENSE FEE")
of fifty thousand U.S. Dollars ($50,000.00)  initially due on the EFFECTIVE DATE
of this Agreement,  and at each annual anniversary of the EFFECTIVE DATE through
the TERM OF THE AGREEMENT, which shall be nonrefundable, except:

                           5.2.1.1 At the sole  discretion of the  LICENSOR,  if
both (i) this  Agreement  is  executed  and the YEARLY  LICENSE  FEE is paid and
received at least 60 days before  manufacture  of LICENSED  PRODUCTS by LICENSOR
and (ii)  LICENSEE  in the  previous  12 months of  business  had a total  gross
revenue of:

                           5.2.1.1.1  Less  than or  equal to two  million  U.S.
Dollars ($2,000,000.00), then for that annual payment only of the YEARLY LICENSE
FEE,  LICENSEE may take a prepaid  discount of forty-nine  thousand U.S. Dollars
($49,000.00) against the YEARLY LICENSE FEE; or

                           5.2.1.1.2   More  than  two  million   U.S.   Dollars
($2,000,000.00)   and  less  than  or  equal  to  four  million   U.S.   Dollars
($4,000,000.00),  then for that annual  payment only of the YEARLY  LICENSE FEE,
LICENSEE  may take a prepaid  discount  of  forty-seven  thousand  U.S.  Dollars
($47,000.00) against the YEARLY LICENSE FEE; or

                           5.2.1.1.3   More  than  four  million  U.S.   Dollars
($4,000,000.00)   and  less  than  or  equal  to  six   million   U.S.   Dollars
($6,000,000.00),  then for that annual  payment only of the YEARLY  LICENSE FEE,
LICENSEE  may  take a  prepaid  discount  of  forty-six  thousand  U.S.  Dollars
($46,000.00) against the YEARLY LICENSE FEE; or

                                       7
<PAGE>

                           5.2.1.1.4   More  than  six  million   U.S.   Dollars
($6,000,000.00)   and  less  than  or  equal  to  ten   million   U.S.   Dollars
($10,000,000.00),  then for that annual  payment only of the YEARLY LICENSE FEE,
LICENSEE  may take a  prepaid  discount  of  forty-four  thousand  U.S.  Dollars
($44,000.00) against the YEARLY LICENSE FEE; or

                           5.2.1.1.5   More  than  ten  million   U.S.   Dollars
($10,000,000.00)  and  less  than or  equal  to  fifteen  million  U.S.  Dollars
($15,000,000.00),  then for that annual  payment only of the YEARLY LICENSE FEE,
LICENSEE  may  take a  prepaid  discount  of  forty-two  thousand  U.S.  Dollars
($42,000.00) against the YEARLY LICENSE FEE; or

                           5.2.1.1.6  More than  fifteen  million  U.S.  Dollars
($15,000,000.00),  then for that annual  payment only of the YEARLY LICENSE FEE,
LICENSEE may take a prepaid discount of forty thousand U.S. Dollars ($40,000.00)
against the YEARLY LICENSE FEE.

                  5.2.2 A Royalty on each and every FINISHED PRODUCT integrating
LICENSED PRODUCT that is manufactured,  used, sold, or otherwise commercialized,
said Royalty being either:

                           5.2.2.1 The greater of either (i) twenty-five percent
(25%) of the NET SALES  PRICE of a  FINISHED  PRODUCT or (ii) two  hundred  U.S.
Dollars  ($200.00) for the first two (2)  electroacoustic  transducers  within a
FINISHED  PRODUCT  and an  additional  fifty  U.S.  Dollars  ($50.00)  for  each
additional electroacoustic transducer in the same FINISHED PRODUCT;

                           5.2.2.2 If  Royalty is paid at least  sixty (60) days
in advance of manufacture of FINISHED  PRODUCTS via purchase of special  prepaid

                                       8
<PAGE>

royalty  stickers in  one-thousand  U.S. Dollar  ($1,000.00)  minimum lots, then
Royalty for each FINISHED PRODUCT (one single cabinet or enclosure) is:

                                    5.2.2.2.1  Two  and  one-half  U.S.  Dollars
($2.50) if the  FINISHED  PRODUCT  does not exceed  twenty-five  (25)  pounds in
weight; or

                                    5.2.2.2.2  Ten U.S.  Cents  ($0.10) for each
and every pound if the FINISHED  PRODUCT does exceed  twenty-five (25) pounds in
weight.

                           5.2.2.3  For  vehicular   applications   of  LICENSED
PRODUCTS, if Royalty is paid, at least sixty (60) days in advance of manufacture
or  integration of LICENSED  PRODUCTS into the vehicle,  via purchase of special
prepaid royalty stickers,  the Royalty for private cars, trucks,  planes, boats,
and RVs is one  hundred-fifty  U.S.  Dollars  ($150.00)  for the  first  two (2)
electroacoustic transducers in the vehicle and an additional twenty U.S. Dollars
($20.00) for each  additional  electroacoustic  transducer  in the same vehicle.
Special  prepaid  royalty  stickers  shall be issued by LICENSOR with the serial
number of the vehicle  and  LICENSEE  shall  visibly  affix the special  prepaid
royalty stickers to the  driver's/pilot's  door jamb, or adjacent to the vehicle
serial number,  or another location  determined and specified in writing at time
of purchase of special prepaid royalty stickers.

         5.3 The Parties  have  agreed to the  Royalty on  LICENSED  PRODUCTS as
stated herein as a mutually  acceptable,  convenient and practical measure of an
appropriate  royalty  for  the  use  of the  LICENSED  PRODUCTS  throughout  the
TERRITORY. In order to ensure that the NET SALES PRICE of FINISHED PRODUCTS sold
by LICENSEE is readily ascertainable, LICENSEE agrees that all FINISHED PRODUCTS
sold or otherwise  disposed of by LICENSEE  shall be separately  invoiced for no
less than fair market value.

                                       9
<PAGE>

SECTION 6 - SAMPLES AND QUALITY CONTROL

         6.1 LICENSEE  shall prior to initial sale of LICENSED  PRODUCT,  and at
any time requested by LICENSOR  provide,  at no charge to LICENSOR,  up to three
(3)  pairs/sets  of  any  product  including   FINISHED  PRODUCTS   (hereinafter
"SAMPLES")  requested by LICENSOR that incorporate  LICENSED PRODUCTS.  LICENSEE
shall have the  SAMPLES  delivered  to LICENSOR  within  thirty (30) days of the
request,  at no charge and freight prepaid.  The SAMPLES  thereafter  become the
sole property of LICENSOR.

         6.2  Before  LICENSEE  offers  for  sale or sells  any of the  LICENSED
PRODUCTS,  the Parties shall agree upon and reduce to writing quality  standards
for the LICENSED PRODUCTS to ensure a technically  satisfactory  exploitation of
the LICENSED PRODUCTS and the CROSSOVER TECHNOLOGY embodied herein and to ensure
that the LICENSED  PRODUCTS  made by LICENSEE  conform to the quality  standards
that are  expected by LICENSOR.  LICENSEE  agrees that all units of the LICENSED
PRODUCTS and FINISHED PRODUCTS sold under this Agreement shall meet such quality
standards.  LICENSEE shall not commence the sale of the LICENSED PRODUCTS unless
and until LICENSEE has first provided LICENSOR with SAMPLES for inspection.

SECTION 7 - PAYMENTS, RECORDS AND REPORTS

         7.1 The  obligation  of LICENSEE to pay the Royalty  with  respect to a
LICENSED  PRODUCT  shall arise at the time the  LICENSED  PRODUCT is first sold,
leased or otherwise disposed of by LICENSEE.  A LICENSED PRODUCT shall be deemed
to have been sold, leased or otherwise  disposed of when it is first invoiced or
shipped to a customer by LICENSEE, whichever comes first.

                                       10
<PAGE>

         7.2 During the TERM OF THE AGREEMENT, within thirty (30) days after the
end of each calendar  quarter  following the Effective  Date of this  Agreement,
LICENSEE  shall send to LICENSOR a written  statement  identifying  the LICENSED
PRODUCTS  including  FINISHED  PRODUCTS for which royalties are payable for such
period and showing the total number of such LICENSED  PRODUCTS  sold,  leased or
otherwise disposed of by LICENSEE during such period and the amount of Royalties
due  and  payable  thereon,  including  the  calculations  used by  LICENSEE  to
determine the amount. The written  statements  furnished to LICENSOR by LICENSEE
shall be maintained in confidence by LICENSOR.

         7.3 Concurrent with the written  statement to be furnished to LICENSOR,
LICENSEE shall pay to LICENSOR the full amount of Royalties  shown thereon,  the
payment to also include any due and unpaid  YEARLY  LICENSE FEE. In the event of
LICENSEE's  failure to make any required payment on or before the required date,
a supplemental  royalty equal to five percent (5%) of the amount  otherwise due,
or the maximum  amount  permitted by law,  whichever  is less,  shall be paid by
LICENSEE for each month or portion thereof that the payment is late by more than
five (5) days.

         7.4  The  royalty   report  shall  be   certified   by  an   authorized
representative  of LICENSEE and shall state the number of LICENSED  PRODUCTS and
FINISHED PRODUCTS sold, leased or otherwise disposed of. In the event a LICENSED
PRODUCT is sold at varying NET SALES PRICES,  then the report shall indicate the
number of LICENSED  PRODUCTS  sold at each NETS SALES PRICE.  Further,  LICENSEE
shall furnish whatever  additional  information  LICENSOR may reasonably request
from time to time to enable  LICENSOR to verify the calculation of Royalties due
pursuant to this Agreement.

                                       11
<PAGE>

         7.5 All monies  payable  hereunder  shall be tendered in United  States
Dollars in such locations in the United States as LICENSOR may from time to time
designate by written  notice.  All payments under this  Agreement  shall be made
payable to LICENSOR and shall initially until further notice be delivered to the
LICENSOR's address as specified above.

         7.6 It is expressly  understood  and agreed by the Parties  hereto that
all  computations  relating to determination of the amounts of Royalties due and
payable   pursuant  to  this  Agreement   shall  be  made  in  accordance   with
internationally  recognized  and  generally  accepted  accounting  principles as
reflected  in the  practice  of  certified  independent  public  accountants  of
international reputation.

         7.7 LICENSEE shall keep proper books of account regarding all sales and
manufacturing  of LICENSED  PRODUCTS.  Upon reasonable  request by the LICENSOR,
such books of account  shall be made  available at  reasonable  times and places
provided  by the  LICENSOR  (including  the  right to  inspect,  copy,  and make
abstracts  therefrom) for the purpose of verifying the royalties due or paid, or
for the purpose of determining compliance of other provisions of this Agreement.

SECTION 8 - PATENTS AND TRADEMARKS

         8.1  LICENSEE is not  obligated  to pay any costs,  fees,  and expenses
incurred in obtaining  patent  protection or trademark  protection in the United
States  related to the  CROSSOVER  TECHNOLOGY  and  TRADEMARKS  or other related
trademarks  including  related icons or other  trademarks and icons specified by
LICENSOR for designating use of the CROSSOVER TECHNOLOGY by LICENSEE in LICENSED
PRODUCTS.

         8.2  LICENSOR  shall  have the  sole  right to  direct  the  continuing
prosecution of the LETTERS PATENT including pending patent applications directed

                                       12
<PAGE>

to the CROSSOVER TECHNOLOGY and/or related TECHNICAL INFORMATION,  including any
and all improvements thereto.

         8.3 During the TERM OF THE  AGREEMENT,  the LICENSEE  shall disclose to
LICENSOR any  improvements or  modifications  relating to the LICENSED  PRODUCTS
which are developed by the LICENSEE or the LICENSEE's employees,  contractors or
agents.  All improvements  shall be the exclusive property of LICENSOR and shall
be subject to the license  granted in  Agreement  to  LICENSEE.  LICENSEE  shall
promptly assign to LICENSOR,  in perpetuity and throughout the world, all rights
in and to all  improvements  to CROSSOVER  TECHNOLOGY and LICENSED  PRODUCTS and
LICENSOR shall have the sole and exclusive  right,  but not the  obligation,  to
prepare, file and prosecute,  in the name of LICENSOR and at LICENSOR's expense,
application  for patents in the United States and  throughout  the world for all
such   improvements.   LICENSEE  shall  provide  LICENSOR  with  all  documents,
information  and  assistance as may be required by LICENSOR in  connection  with
such applications.

         8.4 If during the TERM OF THE  AGREEMENT,  LICENSEE shall file a patent
application  or be granted a patent,  or be granted the right to grant  others a
license  under any patent  application  or patent,  anywhere in the world,  with
respect to derivatives of CROSSOVER TECHNOLOGY or any other aspect of LICENSOR's
technology,   LICENSEE  agrees  to,  and  hereby  does,  grant  to  LICENSOR  an
irrevocable,  non-exclusive,  royalty-free, worldwide license (with the right to
sub-license  only to a parent or  subsidiary of LICENSOR) in perpetuity to make,
have made,  use, sell lease or otherwise  dispose of, and import items,  devices
and products covered by any such patent or patent application,  and practice any
methods covered by any such patent or patent application.

                                       13
<PAGE>

         8.5 LICENSE  agrees to mark  LICENSED  PRODUCTS,  or in the event their
size or  configuration  makes such  marking  impractical,  their  containers  or
labels,  as well as all  literature  describing  the LICENSED  PRODUCTS with the
respective  patent  numbers of  LETTERS  PATENT  and any  corresponding  "Patent
Pending" designators for any pending patent applications.

         8.6 In all literature  originated by LICENSEE that relates to CROSSOVER
TECHNOLOGY,  LICENSEE  agrees  to  prominently  print  the  legend  "DiAural(TM)
Technology"  or other  descriptive  legend  as  LICENSOR  may from  time to time
designate.  Except for advertising and marketing materials, said legend shall be
in print no less distinct and in size than the accompanying text.

         8.7 On all LICENSED PRODUCTS and FINISHED PRODUCTS,  LICENSEE agrees to
prominently display legends,  trademarks or other identifying icons denoting the
use of CROSSOVER TECHNOLOGY and the identity of LICENSOR as mutually agreed upon
by the Parties in view of  LICENSEE's  specific  LICENSED  PRODUCTS and FINISHED
PRODUCTS.

SECTION 9 - CONFIDENTIAL DISCLOSURE

         9.1 LICENSEE  recognizes that LICENSOR has related to LICENSEE  certain
technology,  know-how  and other  trade  secrets  and  knowledge  ("CONFIDENTIAL
INFORMATION") which may be proprietary to LICENSOR.  LICENSEE agrees to take all
reasonable steps to maintain the confidentiality of any CONFIDENTIAL INFORMATION
provided to LICENSEE by LICENSOR in the  furtherance  of this  Agreement  and to
protect all such CONFIDENTIAL INFORMATION with at least the same diligence, care
and precaution that the LICENSEE uses to protect its own  confidential and trade
secret  information,  but in no event less than reasonable care. LICENSEE agrees

                                       14
<PAGE>

to not disclose any  CONFIDENTIAL  INFORMATION to any person not a Party to this
Agreement without the express written consent of LICENSOR.

         9.2  The  LICENSOR   recognizes   that  LICENSEE  also  possesses  like
information  that has great value to LICENSEE.  The LICENSOR also agrees to take
all reasonable steps and precautions  necessary to maintain the propriety nature
of such information.

         9.3   The   Parties'    obligations   with   respect   to   maintaining
confidentiality  shall  remain  effective,  notwithstanding  the  expiration  or
termination of this Agreement.

         9.4  With  respect  to  any  of  LICENSOR'S  CONFIDENTIAL   INFORMATION
disclosed by LICENSEE to a third party, the LICENSEE shall be directly liable to
the  LICENSOR  for any  damages  incurred  as a result  of  unauthorized  use or
disclosure of CONFIDENTIAL INFORMATION including, without limitation, damages in
the form of attorney's  fees and costs incurred by the LICENSOR in any action or
proceeding  against a third party seeking redress for such  unauthorized  use of
CONFIDENTIAL INFORMATION.

         9.5 Except as otherwise  provided for in this Agreement relating to the
utilization  of CROSSOVER  TECHNOLOGY in LICENSED  PRODUCTS,  LICENSEE shall not
attempt to reverse engineer or otherwise  attempt to reconstruct or discover any
underlying ideas relating to the CROSSOVER TECHNOLOGY.

SECTION 10 - INFRINGEMENT OF PATENT RIGHTS

         10.1  In  the  event  that  LICENSEE   suspects  or  becomes  aware  of
unauthorized or improper use or infringement of any LETTERS  PATENTS,  TECHNICAL
INFORMATION or TRADEMARKS,  LICENSEE shall immediately notify LICENSOR. LICENSOR
may, at its option,  elect to undertake and control the prosecution,  defense or
settlement of any legal action in connection  with such alleged  improper use or
infringement, and LICENSEE shall have no right to initiate, prosecute, defend or

                                       15
<PAGE>

settle any claim,  suit or action  against  or by any such third  party  without
LICENSOR's prior written consent. LICENSOR shall have the first right to enforce
the LETTERS PATENT and TECHNICAL  INFORMATION bearing all costs,  expenses,  and
attorneys'  fees but also  maintaining  for  itself all  damages  awarded in the
litigation.

SECTION 11 - TERM AND TERMINATION

         11.1 The original  term of Agreement  shall  commence  upon the signing
hereof and continue in full force and effect  through the TERM OF THE  AGREEMENT
except as otherwise provided herein.

         11.2 LICENSOR shall have the right to terminate  this Agreement  during
the TERM OF THE  AGREEMENT  if LICENSEE is in arrears for ninety (90) days after
the due date of any payments  including  Royalties and YEARLY LICENSE FEES or if
LICENSEE is declared bankrupt and a distribution to creditors is ordered.

         11.3 The LICENSOR shall also have the right to terminate this Agreement
during the TERM OF THE AGREEMENT if LICENSEE  generates  less than  ten-thousand
U.S.  Dollars  ($10,000.00)  in Royalties in any twelve (12)  consecutive  month
period beginning with the twenty-fourth  (24) month following the Effective Date
of the Agreement and continuing thereafter through the TERM OF THE AGREEMENT.

         11.4.1  The  LICENSOR  shall  also  have the  right to  terminate  this
Agreement  during the TERM OF THE AGREEMENT at LICENSOR'S  sole  discretion upon
written  notification  to the  LICENSEE  at least  ninety days (90) prior to the
annual  anniversary of the EFFECTIVE  DATE of this  Agreement,  thereby  stating
LICENSOR'S  intent not to renew  LICENSEE'S  licenses  to  LICENSOR'S  CROSSOVER
TECHNOLOGY.

                                       16
<PAGE>

         11.4.2 The LICENSEE  shall have the right to terminate  this  Agreement
during the TERM OF THE  AGREEMENT at  LICENSEE'S  sole  discretion  upon written
notification  to the  LICENSOR  at least  ninety  days (90)  prior to the annual
anniversary of the EFFECTIVE DATE of this Agreement,  thereby stating LICENSEE'S
intent not to renew LICENSEE'S licenses to LICENSOR'S CROSSOVER TECHNOLOGY

         11.5 In the  event  that  either  Party  has the  right  to  terminate,
termination shall first be noticed in writing to the other Party. Except for the
right to terminate under section 11.4,  both Parties  recognize that before this
Agreement can be terminated,  a one-hundred twenty (120) day period in which the
defaulting  Party may cure after notice of termination is granted to each Party.
If the defaulting Party's outstanding  obligations or capabilities are corrected
so as to meet the obligations  under this Agreement,  and this occurs within the
one hundred  twenty (120) day period,  this  Agreement  shall not be terminated.
However, if the defaulting Party is unable to cure during the one hundred twenty
(120) day period,  this Agreement shall be terminated  sixty (60) days after the
conclusion of the one hundred twenty (120) day period.

SECTION 12 - INDEMNIFICATION

         12.1 LICENSEE hereby  indemnifies,  holds harmless and agrees to defend
LICENSOR  from and against all claims,  damages,  expenses  (including,  without
limitation,  attorney's fees and reasonable  investigative and discovery costs),
liabilities  and  judgments  on account of injury to persons,  loss of life,  or
damage   to   property   occurring   from   LICENSEE's   sale,   marketing   and
commercialization  of  the  LICENSED  PRODUCTS;   provided,  LICENSEE  does  not
indemnify  LICENSOR against any injury,  loss of life, or damage which is caused
by the active or passive  negligence  of  LICENSOR,  their  agents,  servants or
employees.

                                       17
<PAGE>

         12.2 The Parties'  obligations with respect to  indemnification  herein
shall remain  effective,  notwithstanding  the  expiration or termination of the
Agreement,  as to claims accruing prior to the expiration or termination of this
Agreement.

SECTION 13 - INDEPENDENCE OF THE PARTIES

         13.1 This  Agreement  shall not  constitute  the  designation of either
Party  as a  representative  or  agent of the  other  or as a joint  venture  or
partnership  between the Parties,  nor shall either Party by this Agreement have
the  right  or  opportunity  to  make  any  promise,   guarantee,   warranty  or
representation,  or to assume, create or incur any liability or other obligation
of any kind, express or implied, against or in the name of, or on behalf of, the
other.

SECTION 14 - ASSIGNMENT

         14.1 LICENSEE shall not have the right to assign or otherwise  transfer
this Agreement, without the prior written consent of LICENSOR.

         14.2  LICENSOR  shall have the right to assign  their  right to receive
royalty and other payments to any third party, without the prior written consent
of LICENSEE.  Such  assignments  shall not be deemed effective until LICENSEE is
given notice of such assignment in writing as provided herein.

SECTION 15 - NOTICE

         15.1  All  notices,   demands,  and  other  communications  under  this
Agreement  shall be in writing and deemed to have been duly given and  delivered
one day after being sent by telefax, or five (5) days after posting by certified
mail,  return  receipt  requested,  postage  prepaid to the Parties at the above
addresses.

                                       18
<PAGE>

         15.2 The Parties  hereto may at any time give written notice of changes
of address,  and after such  notices have been  received,  any notice of request
shall thereafter be given to such Party at the changed address.

SECTION 16 - APPLICABLE LAW

         16.1 This  Agreement is entered into  pursuant to the laws of the State
of Utah, and the validity and interpretation of this Agreement shall be governed
by and in  accordance  with the laws of the State of Utah as such law shall from
time to time be in effect,  excluding the choice of law  provisions of any other
state or  jurisdiction.  The Parties  agree that any action for relief  based in
whole or in part on this Agreement (or the breach thereof) or otherwise relating
in whole or in part to this Agreement shall be filed in, and the Parties consent
to personal  jurisdiction  and venue in, the Federal and State Courts closest to
the above-identified place of business of LICENSOR in Ogden, Utah having subject
matter  jurisdiction  over such action.  In any such action between the Parties,
the  prevailing  Party shall be  entitled  to recover (in  addition to any other
relief  awarded  or  granted)  its  reasonable  costs  and  expenses  (including
attorneys' fees) incurred in the proceeding.

SECTION 17 - ATTORNEYS' FEES

         17.1 In the event either  Party brings or commences a legal  proceeding
to enforce any of the terms of this  Agreement or it becomes  necessary  for any
Party to employ the services of any attorney,  either to enforce or to terminate
this  Agreement,  each Party shall bear his own costs,  expenses and  attorneys'
fees incurred thereby with respect to the resolution of such matter.

                                       19
<PAGE>

SECTION 18 - GENERAL PROVISIONS

         18.1 The  Parties  agree  that  this  Agreement  and the  terms of this
Agreement are to be strictly confidential, and neither Party shall disclose this
Agreement or anything  with respect to the terms of this  Agreement to any third
party except: (i) to legal counsel; (ii) auditors;  (iii) to the extent, if any,
required by law;  (iv) in  accordance  with the terms of a  protective  or other
order duly entered in a legal proceeding;  or (v) with the prior written consent
of the other Party.

         18.2 The Parties  hereto have read this Agreement and agree to be bound
by the terms  herein.  The  Parties  further  agree  that this  Agreement  shall
constitute  the complete and exclusive  statement of the agreement  between them
and that this Agreement supersedes all proposals,  written or oral, or any other
communications,  warranties,  representations  or agreements between the Parties
relating to the LICENSED PRODUCTS.

         18.3   No   agreement   changing,   modifying,   amending,   extending,
superseding, discharging or terminating this Agreement or any provisions thereof
shall  be valid  unless  it is in  writing  and is dated  and  signed  by a duly
authorized representative of the Party or Parties to be charged.

         18.4 The  provisions of this  Agreement are severable in the event that
any  provisions  of this  Agreement  shall  be held to be  invalid,  illegal  or
unenforceable.  The  validity,  legality  and  enforceability  of the  remaining
provisions shall not in any way be affected or impaired thereby.

         18.5  Failure of any Party  hereto to  enforce  any  provision  of this
Agreement  or rights with respect  thereto or to exercise any election  provided
for herein,  shall in no way be  considered as a waiver of such right to enforce
any other  provisions or any other elections under this Agreement.  Such failure
of any Party hereto to enforce any  provision  of this  Agreement or rights with
respect thereto or to exercise any election provided for herein, shall in no way

                                       20
<PAGE>

be  considered  as a waiver to enforce the same  provision of this  Agreement or
rights with respect  thereto or to exercise the election  provided for herein at
any time in the future.

         18.6 All the provisions  contained in this  Agreement  shall be binding
upon,  inure to the benefit of and be enforceable  by the respective  successors
and  assigns of the  Parties to the same  extent as if each such  successor  and
assign were named as party to this Agreement.

         18.7 The headings of the Sections  contained herein are for convenience
only and do not define, limit or construe the contents of such Sections.

         18.8 This  Agreement  shall be  interpreted  and construed  only by the
contents  hereof,  and there shall be no presumption or standard of construction
in favor or against either Party.

         18.9 When required by context,  the singular  shall include the plural,
and the neuter gender shall include a person, corporation, firm or association.

         18.10 There  shall be no  liability  on either  Party on account of any
loss,  damage  or  delay  occasioned,   or  caused  by  strikes,  riots,  fires,
insurrection or the elements,  embargoes, failure of carriers, acts of God or of
the public enemy,  compliance with any law,  regulation,  or other  governmental
order,  or any other causes beyond the control of either  Party,  whether or not
similar to the foregoing.

         18.11  This  Agreement  may be  executed  in  any  number  of  original
counterparts,  each of which  shall be  deemed to be an  original,  all of which
constitute one and the same agreement.

                                       21
<PAGE>

         IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be
duly executed as of the day and year first above written.

/s/  Ray L. Kimber                  FOR:  EDGE AUDIO, LLC
-------------------------------     --------------------------------------------

DIAURAL L.L.C.                      By:   /s/ Winthrop Jeanfreau
                                    --------------------------------------------
Ray L. Kimber, President            [handwritten] Winthrop Jeanfreau, President
                                    --------------------------------------------
         "LICENSOR"                          "LICENSEE"

                                       22

<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00028-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00028-of-00352.parquet"}]]